Oracle Health Sciences has launched Oracle Health Sciences OutcomeLogix On Demand 3.0, a web-based, scalable data collection system that enables life science companies and contract research organizations to efficiently capture accurate therapy outcome information from health care providers, as well as patients in late-stage studies.
The newest version of the solution incorporates several features that help meet increasing requirements to improve product safety and demonstrate long-term treatment efficacy. New capabilities that address the increasingly larger, geographically dispersed, and patient-centered nature of observational studies include: increased scalability to support data collection; improved, user-friendly interface; updated prompting tools; enhanced configurability; expanded multi-lingual support.
“Study sponsors and CROs, responding to regulatory mandates for increased post-approval surveillance and the growing need for patient-reported outcomes, are seeking technology solutions from a global, trusted provider to accommodate data collection across vast patient populations,” said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences. “Oracle Health Sciences OutcomeLogix On Demand 3.0 delivers a flexible solution that is not only cost-effective to deploy and maintain, but is also easy for health care providers and patients to navigate.”